Literature DB >> 28814816

Osteoarthritis: Chondroitin sulfate - CONCEPT clear, uncertainties unchanged.

Gabriel Herrero-Beaumont1, Raquel Largo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28814816     DOI： 10.1038/nrrheum.2017.131

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  9 in total

1.  Osteoarthritis: a progressive disease with changing phenotypes.

Authors:  Santos Castañeda; Jorge A Roman-Blas; Raquel Largo; Gabriel Herrero-Beaumont
Journal:  Rheumatology (Oxford)       Date:  2013-07-22       Impact factor: 7.580

2.  Measurement error and the replication crisis.

Authors:  Eric Loken; Andrew Gelman
Journal:  Science       Date:  2017-02-10       Impact factor: 47.728

Review 3.  Chondroitin for osteoarthritis.

Authors:  Jasvinder A Singh; Shahrzad Noorbaloochi; Roderick MacDonald; Lara J Maxwell
Journal:  Cochrane Database Syst Rev       Date:  2015-01-28

4.  Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Jorge A Roman-Blas; Santos Castañeda; Olga Sánchez-Pernaute; Raquel Largo; Gabriel Herrero-Beaumont
Journal:  Arthritis Rheumatol       Date:  2017-01       Impact factor: 10.995

5.  Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis.

Authors:  Bruno R da Costa; Stephan Reichenbach; Noah Keller; Linda Nartey; Simon Wandel; Peter Jüni; Sven Trelle
Journal:  Lancet       Date:  2017-07-08       Impact factor: 79.321

6.  Chondroitin sulfate improves synovitis in rabbits with chronic antigen-induced arthritis.

Authors:  R Largo; J A Roman-Blas; J Moreno-Rubio; O Sánchez-Pernaute; M J Martínez-Calatrava; S Castañeda; G Herrero-Beaumont
Journal:  Osteoarthritis Cartilage       Date:  2010-04-28       Impact factor: 6.576

7.  Effect of chondroitin sulphate in a rabbit model of atherosclerosis aggravated by chronic arthritis.

Authors:  G Herrero-Beaumont; M E Marcos; O Sánchez-Pernaute; R Granados; L Ortega; E Montell; J Vergés; J Egido; R Largo
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

Review 8.  Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement.

Authors:  J-Y Reginster; S Reiter-Niesert; O Bruyère; F Berenbaum; M-L Brandi; J Branco; J-P Devogelaer; G Herrero-Beaumont; J Kanis; S Maggi; E Maheu; P Richette; R Rizzoli; C Cooper
Journal:  Osteoarthritis Cartilage       Date:  2015-07-14       Impact factor: 6.576

9.  Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT).

Authors:  Jean-Yves Reginster; Jean Dudler; Tomasz Blicharski; Karel Pavelka
Journal:  Ann Rheum Dis       Date:  2017-05-22       Impact factor: 19.103
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.